<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05128084</url>
  </required_header>
  <id_info>
    <org_study_id>7977</org_study_id>
    <nct_id>NCT05128084</nct_id>
  </id_info>
  <brief_title>Amotosalen and Platelet Transfusion in Pediatric Heart Surgery</brief_title>
  <acronym>TransPédia</acronym>
  <official_title>Platelet Transfusion in Pediatric Heart Surgery and Impact of Amotosalen Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      High level of security during blood transfusion has been achieved by donor selection and&#xD;
      pathogen detection using serology or direct identification. Nevertheless, blood banking&#xD;
      becomes hazardous during epidemic outbreaks or facing new pathogens. Amotosalen, a psoralen,&#xD;
      targets nucleic acids and destroys them after ultraviolet exposure, resulting in inactivation&#xD;
      of pathogens.&#xD;
&#xD;
      Treatment inoccuity and efficacy have been demonstrated but preservation of platelet&#xD;
      functions after treatment is still debated. Previous studies focused on hematological&#xD;
      patients. There is no evidence for an increased requirement of transfused platelets to&#xD;
      achieve platelet count target. Studies in heart surgery are lacking.&#xD;
&#xD;
      The investigators perform a multicenter, retrospective, &quot;before/after&quot;, controlled study in&#xD;
      minor patients requiring heart surgery with cardiopulmonary bypass. One center (Strasbourg)&#xD;
      uses Amotosalen-treated platelet concentrates since 2006 (control arm). This treatment&#xD;
      becomes available in Bordeaux in October 2017 (intervention arm). There is two periods of&#xD;
      inclusion: one &quot;before&quot; (January 2016 to June 2017) and one &quot;after&quot; (January 2018 to June&#xD;
      2019).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Retrospective study of the non-inferiority of treatment with Amotosalen of platelet concentrates over transfusion during pediatric cardiac surgery</measure>
    <time_frame>Files analysed retrospectively from January 01, 2016 to June 30, 2019 will be examined]</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Congenital Heart Disease in Children</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Minor patient having had cardiac surgery act under cardiopulmonary bypass for correction of&#xD;
        congenital heart disease&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Minor patient (&lt;18 years old)&#xD;
&#xD;
          -  Cardiac surgery act under cardiopulmonary bypass for correction of congenital heart&#xD;
             disease&#xD;
&#xD;
          -  Platelet transfusion for any reason&#xD;
&#xD;
          -  Cardiac surgery performed at Bordeaux or Strasbourg University Hospital over two&#xD;
             periods:&#xD;
&#xD;
               -  Period A: January 01, 2016 - June 30, 2017 (before treatment)&#xD;
&#xD;
               -  Period B: January 01, 2018 - June 30, 2019 (after treatment)&#xD;
&#xD;
          -  Subject (and / or his parental authority) not having expressed, after information, his&#xD;
             opposition to the reuse of his data for the purposes of this research&#xD;
&#xD;
        Exclusion criteria&#xD;
&#xD;
          -  Subject (and / or his parental authority) having expressed, after information, his&#xD;
             opposition to the reuse of his data for the purposes of this research&#xD;
&#xD;
          -  Presence or installation of transient circulatory assistance (outside of the CEC) or&#xD;
             definitive&#xD;
&#xD;
          -  Heart or cardiopulmonary transplantation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>17 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Xavier DELABRANCHE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Service d'Anesthésie et Réanimation chirurgicale - Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xavier DELABRANCHE, MD</last_name>
    <phone>33 3 69 55 09 36</phone>
    <email>xavier.delabranche@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Saïd CHAYER, PhD, HDR</last_name>
    <email>said.chayer@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service d'Anesthésie et Réanimation chirurgicale - Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier DELABRANCHE, MD</last_name>
      <phone>33 3 69 55 09 36</phone>
      <email>xavier.delabranche@chru-strasbourg.fr</email>
    </contact>
    <contact_backup>
      <last_name>Saïd CHAYER, PhD, HDR</last_name>
      <email>said.chayer@chru-strasbourg.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Xavier DELABRANCHE, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Paul-Michel MERTES, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>François SEVERAC, Statistician</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne ROCHE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 12, 2021</study_first_submitted>
  <study_first_submitted_qc>November 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2021</study_first_posted>
  <last_update_submitted>November 18, 2021</last_update_submitted>
  <last_update_submitted_qc>November 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Congenital Heart</keyword>
  <keyword>Platelet transfusion</keyword>
  <keyword>Procoagulant drugs</keyword>
  <keyword>Amotosalen</keyword>
  <keyword>Pediatric heart surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

